//

China Biologic Products To Host Earnings Conference Call on April 1, 2011 at 7:00 a.m. EDT

PR Newswire
TAI'AN, China
Mar 30, 2011

TAI'AN, China, March 30, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host its earnings conference call and live webcast covering the year ended December 31, 2010 in April 1, 2011 at 7:00 a.m. EDT (New York), which is also 7:00 p.m. in China on the same day.

Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer.

The dial-in details for the live conference call are:


    U.S. toll-free number     1 866 549 1292
    Mainland China toll-
     free number                400 681 6949
    Hong Kong local access         3005 2050
    International toll
     number                   +852 3005 2050
    Participant pass code   674 477#

A telephone replay of the call will be available after the conclusion of the conference all through 8:00 a.m. EDT on April 8, 2011.

The dial-in details for the telephone replay are:


    U.S. toll-free number     1 866 753 0743
    Mainland China toll
     free number                800 876 8594
    Hong Kong local access         3005 2020
    International dial-in
     toll number              +852 3005 2020
    Replay pass code        138 012#

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd., and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently one of the leading plasma-based biopharmaceutical companies in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. For more information, please see the Company's website http://www.chinabiologic.com.

Company Contact


                                  Mr. Y. Tristan Kuo
                                Chief Financial Officer
                             China Biologic Products, Inc.
                                 Tel: +86 53 8620 2206
                              Email: IR@chinabiologic.com
                                 www.chinabiologic.com

SOURCE China Biologic Products, Inc.

SOURCE: China Biologic Products, Inc.

China Biologic Products To Host Earnings Conference Call on April 1, 2011 at 7:00 a.m. EDT

PR Newswire

TAI'AN, China, March 30, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host its earnings conference call and live webcast covering the year ended December 31, 2010 in April 1, 2011 at 7:00 a.m. EDT (New York), which is also 7:00 p.m. in China on the same day.

Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer.

The dial-in details for the live conference call are:

U.S. toll-free number

1 866 549 1292

Mainland China toll-free number

400 681 6949

Hong Kong local access

3005 2050

International toll number

+852 3005 2050

Participant pass code

674 477#



A telephone replay of the call will be available after the conclusion of the conference all through 8:00 a.m. EDT on April 8, 2011.

The dial-in details for the telephone replay are:

U.S. toll-free number

1 866 753 0743

Mainland China toll free number

800 876 8594

Hong Kong local access

3005 2020

International dial-in toll number

+852 3005 2020

Replay pass code

138 012#



About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd., and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently one of the leading plasma-based biopharmaceutical companies in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. For more information, please see the Company's website http://www.chinabiologic.com.

Company Contact

Mr. Y. Tristan Kuo

Chief Financial Officer

China Biologic Products, Inc.

Tel: +86 53 8620 2206

Email: IR@chinabiologic.com

www.chinabiologic.com



SOURCE China Biologic Products, Inc.

Web Site: http://www.chinabiologic.com


print email rss
© 2014 China Biologic Products, Inc. All Rights Reserved.